| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5734848 | Surgery | 2017 | 7 Pages |
Abstract
The risk of hepatocellular carcinoma recurrence after orthotopic liver transplant was low, at 6.4%, in this cohort. Low pretransplant serum cholesterol was the strongest predictor of recurrence and may help clinicians risk stratify patients for appropriate post-transplant monitoring and follow-up.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
E. Dudley BA, C. Gunnar BS, Kenneth D. MD, PhD, Prabhakar K. MD, David J. PharmD, BCPS,